Alejandro Murad currently serves as the Head of US Discovery Biology at UCB, a position held since February 2022. Previously, Alejandro was the Director of Neurology Biology at Skyhawk Therapeutics from 2019 to 2021 and worked as a Consultant at Biotech Consulting in mid-2019. Alejandro's prior experience includes notable roles at FORMA Therapeutics as Principal Scientist and Sequential Founder, leading the Neuroscience Biology Group, and as a Senior Scientist. Alejandro contributed to cancer metabolism at Agios as a Scientist and Project Team Leader, and engaged in neuroscience target identification at Novartis as a Presidential Fellow. Alejandro's academic background includes a PhD in Neurobiology from UMass Chan Medical School and a Master of Science in Biotechnology from Universidad Nacional de Quilmes. Additionally, Alejandro has held teaching and research positions throughout educational pursuits.
This person is not in any teams
This person is not in any offices